Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Altimmune (ALT) Net Margin (2016 - 2025)

Altimmune (ALT) has disclosed Net Margin for 16 consecutive years, with 222653.85% as the latest value for Q4 2025.

  • Quarterly Net Margin fell 108176615.0% to 222653.85% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 6939.02% through Dec 2025, up 2635098.0% year-over-year, with the annual reading at 6939.02% for FY2025, 2635098.0% up from the prior year.
  • Net Margin for Q4 2025 was 222653.85% at Altimmune, up from 380280.0% in the prior quarter.
  • The five-year high for Net Margin was 1304420.0% in Q4 2024, with the low at 1175650.0% in Q3 2022.
  • Average Net Margin over 5 years is 150771.5%, with a median of 89596.25% recorded in 2023.
  • The sharpest move saw Net Margin crashed -115444114bps in 2022, then skyrocketed 121237676bps in 2024.
  • Over 5 years, Net Margin stood at 1669.03% in 2021, then tumbled by -5104bps to 83511.54% in 2022, then surged by 210bps to 92043.24% in 2023, then surged by 1317bps to 1304420.0% in 2024, then plummeted by -83bps to 222653.85% in 2025.
  • According to Business Quant data, Net Margin over the past three periods came in at 222653.85%, 380280.0%, and 442920.0% for Q4 2025, Q3 2025, and Q2 2025 respectively.